Eli Lilly to acquire Prevail Therapeutics for $1.04bn, expanding gene therapy pipeline

Eli Lilly and Company has signed a deal worth up to $1.04 billion to acquire Prevail Therapeutics, a prominent US gene therapy company specializing in ... Read More